Cargando…
Acute Kidney Injury Following Posaconazole for Mucormycosis: SARS-CoV-2 as a Back-Seat Driver
Viruses have been implicated in the causation of several systemic illnesses, either directly or by immune modulation. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not an exception. Due to altered immune regulation, it is often associated with novel clinical manifestations and comp...
Autores principales: | Noor, Mohammad, Amin, Said, Rahim, Fawad, Ali, Barkat, Zafar, Sheraz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387747/ https://www.ncbi.nlm.nih.gov/pubmed/35989786 http://dx.doi.org/10.7759/cureus.27018 |
Ejemplares similares
-
COVID-19 Associated Illnesses From Alveoli to Glomeruli: A Case Report
por: Amin, Said, et al.
Publicado: (2022) -
Impact of COVID-19-associated Mucormycosis in Kidney Transplant Recipients: A Multicenter Cohort Study.
por: Meshram, Hari Shankar, et al.
Publicado: (2021) -
Mucormycosis: A Case Series
por: Yong, Jo Yen, et al.
Publicado: (2023) -
Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants
por: Grau, Santiago, et al.
Publicado: (2015) -
Mucormycosis of the Spine: A Case Report and Review of the Literature
por: Patel, Jaimin, et al.
Publicado: (2022)